Mirum Pharmaceuticals, Inc. (FRA:08D)
Germany
· Delayed Price · Currency is EUR 59.00
+1.00 (1.72%)
Last updated: Dec 4, 2025, 3:29 PM CET
Mirum Pharmaceuticals Revenue
Mirum Pharmaceuticals had revenue of $133.01M USD in the quarter ending September 30, 2025, with 47.17% growth. This brings the company's revenue in the last twelve months to $471.79M, up 53.66% year-over-year. In the year 2024, Mirum Pharmaceuticals had annual revenue of $336.89M with 80.76% growth.
Revenue (ttm)
$471.79M
Revenue Growth
+53.66%
P/S Ratio
7.52
Revenue / Employee
$1.47M
Employees
322
Market Cap
3.03B EUR
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Rheinmetall AG | 11.00B |
| Deutsche Bank Aktiengesellschaft | 29.86B |